Ranked in 1 Practice Areas
2

Band 2

Life Sciences: Regulatory

UK-wide

4 Years Ranked

About

Provided by Sarah Cowlishaw

UK

Practice Areas

Sarah Cowlishaw supports innovative pharmaceutical, biotech, medical device, diagnostic and software technology companies on regulatory, compliance, transactional, and legislative matters. She is a co-chair of Covington’s multidisciplinary Digital Health Initiative, and regularly advises on legal issues presented by digital health technologies including artificial intelligence.

Sarah has played a pivotal role in negotiating supply arrangements for COVID-19 vaccines and non-vaccine COVID-19 related products, including before the European Commission and the UK Government.

She regularly advises the pharma and device industry on regulatory matters, including on borderline determinations, adverse event and other reporting obligations, manufacturing controls, and labeling and promotion. Sarah is also well equipped to advise clients on the new EU Medical Devices Regulation and In Vitro Diagnostic Medical Devices Regulation, and the new UK-specific regulatory regime for medical devices, introduced in January 2021.

On the commercial side, her experience covers the full range of agreements that span the product life-cycle in the life sciences sector. Notably she advised Illumina on its partnership with Genomics England, to sequence up to 500,000 whole genomes for the NHS Genomic Medicine Service. She also advised Sensyne Health on regulatory matters in connection with its £60 million IPO on London’s AIM market.

Chambers Review

Provided by Chambers

UK

Life Sciences: Regulatory - UK-wide
2
Band 2

Sarah Cowlishaw has a growing profile in the sector, for her advisory work pertaining to clinical trials and the negotiation of supply agreements.

Strengths

Provided by Chambers

Discover other Lawyers at
Covington & Burling LLP

Provided by Chambers
Filter by
Band

London (Firms)

Commercial and Corporate Litigation

Craig Pollack
2
Craig Pollack
2
Band 2
Louise Freeman
4
Louise Freeman
4
Band 4
Competition Law

James Marshall
5
James Marshall
5
Band 5
Competition Law: Litigation

Louise Freeman
3
Louise Freeman
3
Band 3
Corporate/M&A: £100-800 million

Louise Nash
4
Louise Nash
4
Band 4

UK-wide

Data Protection & Information Law

Mark Young
2
Mark Young
2
Band 2
Energy & Natural Resources: Power, Renewables & Alternative Energy

Agnieszka Klich
4
Agnieszka Klich
4
Band 4
Financial Services: Non-contentious Regulatory

David Berman
3
David Berman
3
Band 3
Fraud: Civil

Craig Pollack
1
Craig Pollack
1
Band 1
Insurance: Mainly Policyholders

Sonia Campbell
1
Sonia Campbell
1
Band 1
International Arbitration

Jeremy Wilson
4
Jeremy Wilson
4
Band 4
Life Sciences: Regulatory

Grant Castle
1
Grant Castle
1
Band 1
Brian Kelly
2
Brian Kelly
2
Band 2
Sarah Cowlishaw
2
Sarah Cowlishaw
2
Band 2
Life Sciences: Transactional

James Gubbins
1
James Gubbins
1
Band 1
Paul Claydon
1
Paul Claydon
1
Band 1
Daniel Pavin
2
Daniel Pavin
2
Band 2
James M Halstead
3
James M Halstead
3
Band 3
Parliamentary & Public Affairs: Public Affairs

Lisa Peets
1
Lisa Peets
1
Band 1
Private Equity: Venture Capital Investment

James Gubbins
2
James Gubbins
2
Band 2
20 of 24 results